🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objectives of ECCO-2 are: 1) Efficacy: to study whether EQUINACEA ...
Status
Unknown
Location
Hospital de Barbastro
Start Date
2021-06-18
Trial ID
NCT04981314
Treatments Being Tested
This study was conducted to assess the bioequivalence of the ezetimibe tabl...
Status
Completed
Location
Clinical Research Center
Start Date
2017-12-17
Trial ID
NCT05681247
Treatments Being Tested
This study is an open-label, randomized, fed, single dose, crossover study ...
Status
Completed
Location
Korea University Anam Hospital
Start Date
2020-04-08
Trial ID
NCT04260438
The objective of this randomized, single-dose, two-way crossover evaluation...
Status
Completed
Location
Gateway Medical Research, Inc.
Start Date
2001-02
Trial ID
NCT00836576
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, safety, and re...
Status
Completed
Location
Pinnacle Research Group-409 E 10th St
Start Date
2023-10-19
Trial ID
NCT06097273
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of niraparib in ...
Status
Active Not Recruiting
Location
Urology Centers Of Alabama
Start Date
2019-01-25
Trial ID
NCT03748641
Indication: Patients who were diagnosed with Parkinson's disease ≥ 5 years ...
Status
Completed
Location
Yonsei University Health System, Severance Hospital
Start Date
2023-05-09
Trial ID
NCT05887466
This is a trial to evaluate the comparative bioavailability of BMS-986278 t...
Status
Completed
Location
Anaheim Clinical Trials (ACT)
Start Date
2024-12-12
Trial ID
NCT06715683
The study aims to investigate bacteriological efficacy of a nitrofurantoin ...
Status
Completed
Location
Cif Biotec, Medica Sur
Start Date
2007-01
Trial ID
NCT01092351
Treatments Being Tested
Study objectives: To determine Ro resection rate of Docetaxel, cisplatin a...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-06
Trial ID
NCT00343239
Treatments Being Tested